Glycolytic lactate production supports status epilepticus in experimental animals
Annals of Clinical and Translational Neurology · 2023-10 · 10 (10) · 1873-1884
DOI: 10.1002/acn3.51881 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 25.08.2023. Verfasst von Daria Skwarzynska und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neuroscience Graduate Program, University of Virginia, Charlottesville, Virginia, 22908, USA. Hauptthemen laut MEDLINE: Lactic Acid, Status Epilepticus. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NINDS NIH HHS, National Institutes of Health, Brain Institute, University of Virginia.
Abstract (Originalsprache)
Objective
Status epilepticus (SE) requires rapid intervention to prevent cerebral injury and mortality. The ketogenic diet, which bypasses glycolysis, is a promising remedy for patients with refractory SE. We tested the role of glycolytic lactate production in sustaining SE.
Methods
Extracellular lactate and glucose concentration during a seizure and SE in vivo was measured using lactate and glucose biosensors. A lactate dehydrogenase inhibitor, oxamate, blocked pyruvate to lactate conversion during SE. Video‐EEG recordings evaluated seizure duration, severity, and immunohistochemistry was used to determine neuronal loss. Genetically encoded calcium indicator GCaMP7 was used to study the effect of oxamate on CA1 pyramidal neurons in vitro. Spontaneous excitatory postsynaptic currents (sEPSCs) were recorded from CA1 neurons to study oxamate's impact on neurotransmission.
Results
The extracellular glucose concentration dropped rapidly during seizures, and lactate accumulated in the extracellular space. Inhibition of pyruvate to lactate conversion with oxamate terminated SE in mice. There was less neuronal loss in treated compared to control mice. Oxamate perfusion decreased tonic and phasic neuronal activity of GCaMP7‐expressing CA1 pyramidal neurons in vitro. Oxamate application reduced the frequency, but not amplitude of sEPSCs recorded from CA1 neurons, suggesting an effect on the presynaptic glutamatergic neurotransmission.
Interpretation
A single seizure and SE stimulate lactate production. Diminishing pyruvate to lactate conversion with oxamate terminated SE and reduced associated neuronal death. Oxamate reduced neuronal excitability and excitatory neurotransmission at the presynaptic terminal. Glycolytic lactate production sustains SE and is an attractive therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Neuroscience Graduate Program, University of Virginia, Charlottesville, Virginia, 22908, USA.
- Department of Neurology, University of Virginia, Charlottesville, Virginia, 22908, USA.
- UVA Brain Institute, University of Virginia, Charlottesville, Virginia, 22908, USA.
ORCID-Profile: Jaideep Kapur
Förderung
- NINDS NIH HHS
- National Institutes of Health
- Brain Institute, University of Virginia
Zitieren
APA
Skwarzynska, D., Sun, H., Kasprzak, I., Sharma, S., Williamson, J., & Kapur, J. (2023). Glycolytic lactate production supports status epilepticus in experimental animals. Annals of Clinical and Translational Neurology, 10(10), 1873-1884. https://doi.org/10.1002/acn3.51881
Vancouver
Skwarzynska D, Sun H, Kasprzak I, Sharma S, Williamson J, Kapur J. Glycolytic lactate production supports status epilepticus in experimental animals. Annals of Clinical and Translational Neurology. 2023;10(10):1873-1884. doi:10.1002/acn3.51881
BibTeX
@article{Skwarzynska2023,
author = {Skwarzynska, Daria and Sun, Huayu and Kasprzak, Izabela and Sharma, Supriya and Williamson, John and Kapur, Jaideep},
title = {Glycolytic lactate production supports status epilepticus in experimental animals},
journal = {Annals of Clinical and Translational Neurology},
year = {2023},
volume = {10},
number = {10},
pages = {1873--1884},
doi = {10.1002/acn3.51881}
}
EUVIMED